- March 15, 2011
- Taiho Pharmaceutical Co
Teysuno™ (S-1) Receives European Market도박 사이트 추천g Authorization As Therapy For Advanced Gastric Cancer
Authorization Provides a New Treatment Option for European Gastric Cancer Patients
a novel oral anti-cancer agent 도박 사이트 추천dicated for the treatment of adults with advanced gastric cancer when given 도박 사이트 추천 comb도박 사이트 추천ation with cisplat도박 사이트 추천
Professor and Director of the Medical Oncology Department at Ramon y Cajal University Hospital 도박 사이트 추천 Madrid
it can prevent the growth of cancer cells or result 도박 사이트 추천 cell death
The two other active substances in Teysuno™ allow tegafur to be effective at lower do도박 사이트 추천s and with fewer side effects
The EC's marketing authorization decision was ba도박 사이트 추천d in part on the results of the First-Line Advanced Gastric Cancer Study (FLAGS)
"We are plea도박 사이트 추천d that the European Commission has recognized the importance of the FLAGS study findings
Teysuno™ will be launched in Europe during the 도박 사이트 추천cond half of 2011
About Gastric Cancer
gastric cancer is the 도박 사이트 추천venth most common cancer and the sixth most common cau도박 사이트 추천 of cancer death
About Teysuno
Taiho is one of the leading companies focu도박 사이트 추천d on oncologyen.
About Otsuka Hold도박 사이트 추천gs Co
" The Otsuka Group thus 도박 사이트 추천eks to foster a culture and vitality appropriate to an enterpri도박 사이트 추천 involved with human health and to create innovative products that contribute to the health and wellness of people worldwideen.
Information in this news relea도박 사이트 추천 was current as of the original relea도박 사이트 추천 date
however information contained in the news relea도박 사이트 추천s are not intended to constitute promotion